FDA approves Trimel’s Natesto nasal gel to treat men with low testosterone
Natesto, formerly CompleoTRT, is self-administered via a nasal applicator thereby reducing the risk of secondary exposure to testosterone of women or children. Clinical Research of South Florida (CRSA)